# Encentrio Therapeutics, Inc. — Form D

Encentrio Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-03. The offering totals $400K, of which $400K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-04-03
- Form: D
- Accession: 0001971101-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $400K
- Investors: 1
- Date of first sale: 2023-03-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-477694

## Issuer

- Name: Encentrio Therapeutics, Inc.
- CIK: 0001971101
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1800 OWENS ST., SAN FRANCISCO, CA, 94158
- Phone: 41 79 934 94 49

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Johanna Friedl-Naderer | Director | San Francisco, CA |
| Thomas Hecht | Director | Fremont, CA |
| Sung Lee | Director | San Francisco, CA |
| George Scangos | Director | SAN FRANCISCO, CA |
| Natascha Schill | Director | San Francisco, CA |
| Vanina de Verneuil | Executive Officer | San Francisco, CA |
| Sung Lee | Executive Officer | San Francisco, CA |
| Natascha Schill | Executive Officer | San Francisco, CA |

## More

- [CIK 1971101 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1971101&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001971101-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.